To successfully tackle the challenge of AMR, we need to increase support of sustainable antibiotic R&D. However, it is also important that there is both equitable access to, and responsible stewardship of antibiotics, so that these life-saving drugs are available for all patients who need them, whilst being safeguarded for future generations.
This session will explore what initiatives are already underway to achieve this, the roles and responsibilities of different stakeholders, and what new mechanisms we may need.